Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis

Acta Tropica

Volumn 93, Issue 2, 2005, Pages 161-167

  Gonçalves, Gisele Santos ^a   Fernandes, Ana Paula ^a   Souza, Renata Celi Carvalho ^a   Cardoso, Jarbas Eustáquio ^a   De Oliveira Silva, Fernanda ^b   Maciel, Fabiana Cristina ^b   Rabello, Ana ^b   Ferreira, Lucas Antônio Miranda ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

American tegumentary leishmaniasis; Cutaneous leishmaniasis; Hydrophilic formulation; Leishmaniasis; Paromomycin; Topical treatment

Indexed keywords

ANTIMONY; MEGLUMINE ANTIMONATE; PAROMOMYCIN;

LEISHMANIASIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HAMSTER; HYDROPHILICITY; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; MALE; MOUSE; NONHUMAN; PROTOZOAL INFECTION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIMONY SODIUM GLUCONATE; CRICETINAE; FEMALE; GELS; INJECTIONS, INTRAMUSCULAR; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; PAROMOMYCIN; RANDOM ALLOCATION; STATISTICS, NONPARAMETRIC;

ANIMALIA; CRICETINAE; LEISHMANIA AMAZONENSIS; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR;

EID: 12344263066     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2004.10.007     Document Type: Article

References (26)

1. B.A. Arana, C.E. Mendoza, N.R. Rizzo, and A. Kroeger Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala Am. J. Trop. Med. Hyg. 65 2001 466 470
2. M. Barral-Netto, P. Machado, and A. Barral Human cutaneous leishmaniasis: recent advances in physiopathology and treatment Eur. J. Dermatol. 5 1995 104 113
3. J.D. Berman Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years Clin. Infect. Dis. 24 1997 684 703
4. J.D. Berman Current treatment approaches to leishmaniasis Curr. Opin. Infect. Dis. 16 2003 397 401
5. G.A. Castro, D.S. Nascimento, E.A. Nunan, A.P. Fernandes, and L.A.M. Ferreira In vitro skin permeation of paromomycin from topical formulations across normal and stripped hairless mouse skin S. T. P. Pharma. Sci. 13 2003 203 208
6. S.L. Croft, and G.H. Coombs Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs Trends Parasitol. 19 2003 502 508
7. J. El-On, G.P. Jacobs, E. Witztum, and C.L. Greenblatt Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals Antimicrob. Agents Chemother. 26 1984 745 751
8. J. El-On, G.P. Jacobs, and L. Weinrauch Topical chemotherapy of cutaneous leishmaniasis Parasitol. Today 4 1988 76 81
9. A.P. Fernandes, F.A.A. Carvalho, C.A. Tavares, H.C. Santiago, G.A. Castro, W.L. Tafuri, L.A. Ferreira, and R.T. Gazzinelli Combined interleukin-12 and topical chemotherapy for established Leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice J. Infect. Dis. 183 2001 1646 1652
10. L.S. Ferreira, R.C.C. Souza, D.S. Nascimento, A.P. Fernandes, and L.A.M. Ferreira Desenvolvimento de formulações hidrofílicas para tratamento tópico da leishmaniose cutânea Rev. Soc. Bras. Med. Trop. 35 2002 S113 S117
11. S.A. Grevelink, and E.A. Lerner Leishmaniasis J. Am. Acad. Dermatol. 34 1996 257 272
12. M. Grogl, B.G. Schuster, W.Y. Ellis, and J.D. Berman Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (aminosidine) and gentamycin J. Parasitol. 85 1999 354 359
13. J. Li, S. Sutterwala, and J.P. Farrell Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production Infect. Immun. 65 1997 3225 3230
14. P.D. Marsden Pentavalent antimonials old drugs for new diseases Rev. Soc. Bras. Med. Trop. 18 1985 187 198
15. E.S.A. Moreira, C. Anacleto, and M.L.P. Peixoto Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility Parasitol. Res. 84 1998 720 726
16. H.W. Murray, C. Montelibano, R. Peterson, and J.P. Sypek Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasis J. Infect. Dis. 182 2000 1497 1502
17. G.S. Nabors, and J.P. Farrell Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody Am. J. Trop. Med. Hyg. 53 1995 55 60
18. R.A. Neal, S. Allen, N. McCoy, P. Olliaro, and S.L. Croft The sensitivity of Leishmania species to aminosidine J. Antimicrob. Chemother. 35 1995 577 584
19. G.A.S. Romero, M.V. Guerra, M.G. Paes, and V.O. Macedo Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate Am. J. Trop. Med. Hyg. 65 2001 456 465
20. G.A.S. Romero, M.V. Guerra, M.G. Paes, and V.O. Macedo Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach Clin. Infect. Dis. 32 2001 1304 1312
21. G.A.S. Romero, H.A. Lessa, V.O. Macedo, E.M. Carvalho, A. Barral, A.V. Magalhães, M.G.O. Orge, M.V.A. Abreu, and P.D. Marsden Estudo terapêutico aberto com sulfato de aminosidine da leishmaniose mucosa causada por Leishmania (Viannia) braziliensis Rev. Soc. Bras. Med. Trop. 29 1996 557 565
22. J.M. Soto, J.T. Toledo, P. Gutierrez, M. Arboleda, R.S. Nicholls, J.R. Padilla, J.D. Berman, C.K. English, and M. Grogl Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study Am. J. Trop. Med. Hyg. 66 2002 147 151
23. J. Soto, P. Fuya, R. Herrera, and J.D. Berman Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study Clin. Infect. Dis. 26 1998 56 58
24. S. Sundar Drug resistance in Indian visceral leishmaniasis Trop. Med. Int. Health 6 2001 849 854
25. V. Yardley, and S.L. Croft A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis Int. J. Antimicrob. Agents 13 2000 243 248
26. G. Wortmann, R.S. Miller, C. Oster, J. Jackson, and N. Aronson A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel Clin. Infect. Dis. 35 2002 261 267